In this episode of Health411, host Dr. Jonathan Karp and producers Daniel Geller and Josh Brewer delve into the groundbreaking world of Casgevy, the first FDA-approved CRISPR/Cas9-based treatment for sickle cell anemia. They explore the science behind this revolutionary gene-editing therapy, its potential implications for patients, and the ethical considerations surrounding genetic interventions in healthcare.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More